Branden S.Homan

Associate

Atlanta + 1.404.581.8704

Connect:

Share

Branden Homan practices corporate law, with a focus on M&A and corporate governance. He advises public and private companies, as well as private equity firms, on domestic and cross-border mergers, acquisitions, corporate restructurings, equity investments, and other complex and strategic transactions.

While in law school, Branden worked for the U.S. Securities & Exchange Commission and the Securities Division of the Georgia Secretary of State's Office.

Experience

  • Asbury Automotive Group sells Wilmington Lexus dealershipJones Day advised Asbury Automotive Group in the sale of Koons Lexus of Wilmington to MileOne Autogroup.
  • Koch Equity invests $400 million in CPM HoldingsJones Day is advising Koch Equity Development LLC in connection with its $400 million strategic equity investment in CPM Holdings, Inc., a leading global supplier of engineered process equipment for animal feed, oilseed processing, extrusion, and thermal processing markets.
  • Roper Technologies subsidiary acquires ProPricerJones Day advised Roper Technologies, Inc. in the acquisition by subsidiary Deltek of ProPricer, a leading proposal pricing solution for government contractors and government agencies.
  • Asbury Automotive Group acquires Jim Koons AutomotiveJones Day advised Asbury Automotive Group, Inc. (NYSE: ABG), one of the largest automotive retail and service companies in the U.S., in its acquisition of Jim Koons Automotive Group of Companies for approximately $1.2 billion in cash.
  • Eastman Chemical Company sells Texas City operations to INEOS Acetyls for $490 millionJones Day advised Eastman Chemical Company (NYSE: EMN) on the sale of its Texas City operations to INEOS Acetyls, a global manufacturer and supplier of acetic acid and related chemicals owned by the INEOS Group for approximately $490 million.
  • DEKRA acquires Weiss Technik Environmental Testing LaboratoriesJones Day advised DEKRA North America in the acquisition of the environmental testing laboratories of Weiss Technik Testing Services.
  • restor3d acquires Conformis, Inc.Jones Day advised restor3d, Inc., a leading personalized 3D-printed orthopedic company, on its acquisition of Conformis, Inc. (NASDAQ: CFMS), a leading medical technology company focused on orthopedic patient care.
  • Evoqua merges with Xylem in $7.5 billion all-stock transactionJones Day advised Evoqua Water Technologies Corp. (NYSE: AQUA) in its $7.5 billion stock-for-stock merger with Xylem Inc. (NYSE: XYL).
  • AAR acquires TraxJones Day advised AAR CORP. in the acquisition of Trax USA Corp., a leading independent provider of aircraft MRO and fleet management software, for a purchase price of $120 million in cash, plus up to a $20 million earn-out payment based on specified adjusted revenues in calendar year 2023 and 2024.
  • Stellex completes buyout of David Brown Santasalo GroupJones Day advised Stellex Capital Management LLC on its buyout of DB Santasalo S.à r.l from N4 Partners.
  • Riverside portfolio company acquires Primary IntelligenceJones Day represented The Riverside Company in connection with the acquisition by portfolio company Corporate Visions of Primary Intelligence, a provider of SaaS-based win-loss analysis solutions for B2B companies.
  • Helios Technologies acquires Schultes Precision ManufacturingJones Day advised Helios Technologies, Inc. in the acquisition of Schultes Precision Manufacturing, Inc., highly trusted specialist in manufacturing precision machined components and assemblies for customers requiring very tight tolerances, superior quality, and exceptional value-added manufacturing processes.
  • Roper Technologies sells majority stake in industrial businesses to Clayton Dubilier & Rice, LLC for $2.6 billionJones Day advised Roper Technologies, Inc. on the sale of a majority stake in its industrial businesses, including its entire Process Technologies segment and the industrial businesses within its Measurement & Analytical Solutions segment, to an affiliate of Clayton Dubilier & Rice, LLC, for $2.6 billion in cash and contingent consideration of up to $51 million.
  • Koch invests in Compass MineralsJones Day is advising Koch Minerals & Trading, LLC in connection with its $252 million investment in the common stock of Compass Minerals International, Inc. (NYSE:CMP).
  • Flowers Foods invests in Base CultureJones Day advised Flowers Foods, Inc. in its investment in Base Culture, a fast-growing brand offering better-for-you, gluten-free and grain-free sliced breads and baked goods.
  • Aaron's Company acquires BrandsMart U.S.A. for $230 millionJones Day advised The Aaron's Company, Inc., a leading technology-enabled, omnichannel provider of lease-to-own and purchase solutions, on its acquisition of BrandsMart U.S.A. for $230 million.
  • Roper acquires The Construction JournalJones Day advised Roper Technologies, Inc. in the acquisition by subsidiary ConstructConnect, Inc., of The Construction Journal, Ltd., a leading provider of project data and market intelligence in the construction industry.
  • Asbury Automotive completes $600.6 million Shares of Common Stock and $1.4 billion Senior Notes offeringJones Day represented Asbury Automotive Group, Inc. (the "Company") in connection with (i) its underwritten public offering (the "Common Stock Offering") of 3,795,000 Shares of its Common Stock, par value $0.01 per share (the "Shares") resulting in gross proceeds of approximately $600.6 million and (ii) its offering of Senior Notes (the “Notes Offering”), consisting of $800 million aggregate principal amount of 4.625% Senior Notes due 2029 (the “2029 Notes”) and $600 million aggregate principal amount of 5.000% Senior Notes due 2032 (the “2032 Notes” and, together with the 2029 Notes, the “Notes”).
    • View All

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.